Publications

Optimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay

Marrero-Santos KM, Beltrán M, Carrión-Lebrón J, Sanchez-Vegas C, Hamer DH, Barnett ED, Santiago LM, Hunsperger EA

Clin Vaccine Immunol.. 2013 Mar; 20(3):358-62.

Exploring the beliefs, attitudes, and behaviors of MSM engaged in substance use and transactional sex in Ghana

Jennifer Beard, Monica Adhiambo Onyango, Thomas Agyarko-Poku, Ivan Busulwa, Abanish Rizal, Mohammed Brooks, Kofi Akuoko, Kofi Baffuor Opoku, Yaw Adu-Sarkodie

Washington, DC: USAID Project SEARCH; 2013 Mar.

Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease

Ehimen C. Aneni, Davidson H. Hamer, Christopher J. Gill

Tropical Medicine and International Health. 2013 Mar; 18(3):313-327.

Diagnosing Xpert MTB/RIF-negative TB: Impact and cost of alternative algorithms for South Africa

K Schnippel, G Meyer-Rath, L Long, W S Stevens, I Sanne, S Rosen

The South African Medical Journal. 2013 Feb; 103(2).

Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa

Lukas Fenner, Stewart E. Reid, Matthew P. Fox, Daniela Garone, Maureen Wellington, Hans Prozesky, Marcel Zwahlen, Michael Schomaker, Gilles Wandeler, Nzali Kancheya, Andrew Boulle, Robin Wood, German Henostroza, and Matthias Egger

Tropical Medicine and International Health. 2013 Feb; 18(2):194-198.

Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting

Kate Clouse, Audrey Pettifor, Mhairi Maskew, Jean Bassett, Annelies Van Rie, Cynthia Gay, Frieda Behets, Ian Sanne and Matthew P. Fox

AIDS 2013. 2013 Feb; 27(4):645-650.

Novel assessment of a novel meningitis B vaccine

Christopher J Gill

The Lancet-Infectious Diseases. 2013 Feb; 13(5):381–382.

Low Rates of Treatment Failure in Children 2-59 Months Treated for Severe Pneumonia: A Multi-site Pooled Analysis

Matthew P. Fox, Donald M. Thea, Salim Sadruddin, Abdul Bari, Rachael Bonawitz, Tabish Hazir, Yasir Bin Nisar, and Shamim A. Qazi ; for the Pneumonia Studies Group

Clinical Infectious Diseases. 2013 Jan; 56(7):978-987.

Feasibility and Acceptability of a Real-Time Adherence Device among HIV-Positive IDU Patients in China

Mary B. DeSilva, Allen L. Gifford, Xu Keyi, Zhong Li, Cheng Feng, Mohamad Brooks, Mark Harrold, Hu Yueying, Christopher J. Gill, Xie Wubin, Taryn Vian, Jessica Haberer, David Bangsberg, and Lora Sabin

AIDS Research and Treatment. 2013 Jan; 2013:1-6.

Heterogeneous effects of health insurance on out-of-pocket expenditure on medicines in Mexico

Veronika J. Wirtz, Yared Santa Ana Téllez, Edson Servan-Mori, and Leticia Ávila-Burgos

Value in Health. 2013 Jan; 15(5):593-603.

Reforming antiretroviral price negotiations and public procurement: the Mexican experience

Adebiyi Adesina, Veronika J. Wirtz, and Sandra Dratler

Health Policy and Planning. 2013 Jan; 28(1):1-10.

HE2RO Policy Brief 6: THE Benefits of Antiretroviral Therapy for Patients’ Economic Well-Being

Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, Galarraga O

2013 Jan.

Patient Retention From HIV Diagnosis Through One Year on Antiretroviral Therapy at a Primary Health Care Clinic in Johannesburg, South Africa

Kate Clouse, Audrey E. Pettifor, Mhairi Maskew, Jean Bassett, Annelies Van Rie, Frieda Behets, Cynthia Gay, Ian Sanne, and Matthew P. Fox

JAIDS. 2013 Jan; 62(2):39-46.

ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics

Bruce A Larson, Margaret Bii, Sarah Henly-Thomas, Kelly McCoy, Fredrick Sawe, Douglas Shaffer, Sydney Rosen

Journal of the International AIDS Society. 2013 Jan; 16(18026).